지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a common form of vasculitis in childhood. Among the recent trends in Kawasaki disease, it is notable that the prevalence rate is increasing, and the proportion of “incomplete” Kawasaki disease is also increasing. A delayed diagnosis with prolonged fever can cause complications, such as coronary artery aneurysm and decreased myocardial contractility. These complications might lead to significant morbidity and mortality. Kawasaki disease is diagnosed when the patient meets the principal criteria for clinical symptoms. Following the diagnostic criteria can prevent overdiagnosis but lead to missing of the incomplete form of the disease. Therefore, it is important to accurately understand Kawasaki disease. As the coronavirus disease 2019 (COVID-19) pandemic continues, concerns about a novel severe Kawasaki-like disease in children related to COVID-19 emerges. Indeed, there have been several reports of Kawasaki-like disease related to COVID-19 in children. Kawasaki disease is no longer rare and is often encountered at hospitals. This paper will provide useful and accurate information on Kawasaki disease.
목차
등록된 정보가 없습니다.
참고문헌 (63)
참고문헌 신청
Masahiro Ishii / 2020 / History and Future of Treatment for Acute Stage Kawasaki Disease / Korean Circulation Journal 50(2):112~119
McCrindle BW / 2017 / Diagnosis, treatment, and long-term management of Kawasaki disease : a scientific statement for health professionals from the American Heart Association / Circulation 135:e927~e999
Kim GB / 2017 / Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014 / Pediatr Infect Dis J 36:482~485
Ghelani SJ / 2012 / Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines / Pediatr Cardiol 33:1097~1103
Research Committee of the Japanese Society of Pediatric Cardiology / 2014 / Guidelines for medical treatment of acute Kawasaki disease : report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery(2012 revised version) / Pediatr Int 56:135~158
McCrindle BW / 2017 / Diagnosis, treatment, and long-term management of Kawasaki disease : a scientific statement for health professionals from the American Heart Association / Circulation 135:e927~e999
Kim GB / 2017 / Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014 / Pediatr Infect Dis J 36:482~485
Ghelani SJ / 2012 / Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines / Pediatr Cardiol 33:1097~1103
Research Committee of the Japanese Society of Pediatric Cardiology / 2014 / Guidelines for medical treatment of acute Kawasaki disease : report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery(2012 revised version) / Pediatr Int 56:135~158
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Kawasaki Disease During COVID-19 Pandemic in Korea – Data Were Added but Are Needed More
Journal of Korean Medical Science
2022 .05
-
Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
Korean Circulation Journal
2018 .01
-
Editorial : Does any specific infection cause Kawasaki disease?
Clinical and Experimental Pediatrics
2019 .01
-
Analysis of Circular RNAs in the Coronary Arteries of Patients with Kawasaki Disease
지질·동맥경화학회지
2019 .01
-
Circular RNA as a Possible Novel Biomarker for Kawasaki Disease
지질·동맥경화학회지
2019 .01
-
Diagnostic characteristics of supplemental laboratory criteria for incomplete Kawasaki disease in children with complete Kawasaki disease
Clinical and Experimental Pediatrics
2015 .01
-
The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
Korean Circulation Journal
2017 .01
-
Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
Korean Circulation Journal
2019 .01
-
Sensorineural hearing loss in patients with Kawasaki disease
Clinical and Experimental Pediatrics
2015 .01
-
Editorial : Can iron be a risk factor for coronary lesions in Kawasaki disease?
Clinical and Experimental Pediatrics
2019 .01
-
Editorial : Predictive risk factors of coronary artery aneurysms in Kawasaki disease
Clinical and Experimental Pediatrics
2019 .01
-
Diagnostic Applications for Clinical and Imaging Data in Kawasaki Disease with Lymphadenopathy-First-Presentation
Journal of Cardiovascular Imaging
2018 .01
-
Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery Lesions in Kawasaki Diseases?
Korean Circulation Journal
2021 .01
-
Erratum: Significance of Differential Characteristics in Infantile Kawasaki Disease
Korean Circulation Journal
2020 .01
-
Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
Clinical and Experimental Pediatrics
2019 .01
-
Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease
Clinical and Experimental Pediatrics
2019 .01
-
T helper 1 & 2 cytokine profiles in patients with Kawasaki disease
Korean Circulation Journal
2015 .01
-
전형적인 가와사키병 환아와 경부 림프절종대를 주소로 내원하여 가와사키병으로 진단된 환아의 비교
Pediatric Infection and Vaccine
2016 .01
-
Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
Clinical and Experimental Pediatrics
2016 .01
-
A Case of Incomplete Kawasaki Disease Complicated by Acute Coronary Syndrome Initially Diagnosed on Coronary CT Angiography
Korean Circulation Journal
2022 .07
이 논문의 저자 정보
최근 본 자료
댓글(0)
0